Shopping Cart
Remove All
Your shopping cart is currently empty
iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1. iRucaparib-AP6 is a highly efficient and specific PARP1 degrader based on Rucaparib by using the PROTAC approach.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $540 | Backorder | Backorder | |
| 5 mg | $1,600 | Backorder | Backorder | |
| 10 mg | $2,800 | Backorder | Backorder | |
| 50 mg | Inquiry | Backorder | Backorder | |
| 100 mg | Inquiry | Backorder | Backorder |
| Description | iRucaparib-AP6, a non-trapping PARP1 degrader, blocks both the catalytic activity and scaffolding effects of PARP1. iRucaparib-AP6 is a highly efficient and specific PARP1 degrader based on Rucaparib by using the PROTAC approach. |
| Targets&IC50 | PARP1:82 nM (DC50) |
| In vitro | iRucaparib-AP6 (0-10 μM; 24 hours) decreases PARP-1 levels in a dose-dependent manner, with a half-maximal degrading concentration (DC50) of 82 nM (Dmax = 92%). |
| Molecular Weight | 886.96 |
| Formula | C46H55FN6O11 |
| Cas No. | 2410557-00-3 |
| Relative Density. | 1.331 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 50 mg/mL (56.37 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.